Search

Your search keyword '"Vento, Suzanne"' showing total 176 results

Search Constraints

Start Over You searched for: Author "Vento, Suzanne" Remove constraint Author: "Vento, Suzanne"
176 results on '"Vento, Suzanne"'

Search Results

1. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

2. The Significance of Hematuria in Podocytopathies

3. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network

4. Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease

5. Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis

6. Improving data quality in observational research studies: Report of the Cure Glomerulonephropathy (CureGN) network

7. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis

8. Persistent Disease Activity in Patients With Long-Standing Glomerular Disease

9. Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today

10. Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN)

11. Text Messaging for Disease Monitoring in Childhood Nephrotic Syndrome

12. Health-related quality of life in glomerular disease

13. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease

15. An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome

16. Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study

17. Rationale and design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in glomerular diseases: designing the right trial for the right patient, today

18. Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome

19. Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease

20. Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulopathy Network

21. Serially assessed bisphenol A and phthalate exposure and association with kidney function in children with chronic kidney disease in the US and Canada: A longitudinal cohort study

22. Clinical trial of focal segmental glomerulosclerosis in children and young adults

24. Multidimensional Data Integration Identifies Tumor Necrosis Factor Activation in Nephrotic Syndrome: A Model for Precision Nephrology

29. Association Between Perfluoroalkyl Substance Exposure and Renal Function in Children With CKD Enrolled in H3Africa Kidney Disease Research Network

30. Persistent Disease Activity in Patients With Long-Standing Glomerular Disease

32. Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome

36. Association Between Perfluoroalkyl Substance Exposure and Renal Function in Children With CKD Enrolled in H3Africa Kidney Disease Research Network

37. Plasma Zonulin Levels in Childhood Nephrotic Syndrome

38. Health-related quality of life in glomerular disease

39. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease

40. Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

41. Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group

42. Diagnostic yield of renal biopsies: a retrospective single center review

43. Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome

45. An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome

46. Early manifestations of renal disease in patients with tuberous sclerosis complex

48. Exposure to bisphenols and phthalates and association with oxidant stress, insulin resistance, and endothelial dysfunction in children

49. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group

Catalog

Books, media, physical & digital resources